PTC Therapeutics, Inc.
) was a big mover last session, as the company saw its shares
rise by nearly 26% on the day. The move came on solid volume too,
as far more shares changed hands than in a normal session. This
reverses the recent trend of the company, as the stock is now
trading above the volatile price range of $15.82 to $21.86 in the
past one-month time frame.
The company has seen two positive revisions in the past two
months. Besides, its earnings consensus has moved considerably
higher over the same time frame, suggesting that more solid
trading could be ahead for PTCT. So make sure to keep an eye on
this stock going forward to see if this recent jump can turn into
more strength down the road.
PTC Therapeutics currently has a Zacks Rank #3 (Hold) while
Some better performing Med-Drugs stocks include
Elan Corporation, plc
Jazz Pharmaceuticals Public Limited Company
Lannett Company, Inc.
). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment
Research? Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ELAN CP PLC ADR (ELN): Free Stock Analysis
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis
LANNETT INC (LCI): Free Stock Analysis Report
PTC THERAPEUTIC (PTCT): Free Stock Analysis
To read this article on Zacks.com click here.